NCT02298985View on ClinicalTrials.gov

Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2017

Study Completion Date

May 31, 2017

Conditions
Chronic Schizophrenia
Interventions
DRUG

Curcumin

3 g/day (3 capsules/day) for 6 months

DRUG

placebo

3 g/day (3 capsules/day) for 6 months

Trial Locations (2)

84170

Tirat Carmel Mental Health Center, Tirat Carmel

Unknown

Beersheva Mental Health Center, Beersheva

All Listed Sponsors
collaborator

Tirat Carmel Mental Health Center

OTHER_GOV

lead

Beersheva Mental Health Center

OTHER_GOV

NCT02298985 - Curcumin Addition to Antipsychotic Treatment in Chronic Schizophrenia Patients | Biotech Hunter | Biotech Hunter